CSPG4 and neoplasm: The HA-based hydrogel containing CAR-T cells was also used for implantation into the tumor cavity: those HA hydrogel implants gradually released CAR-T cells targeting chondroitin sulfate proteoglycan 4 and this approach enabled to prevent the post-surgery tumor recurrence in a murine model [89].